What is the MitraClip procedure and when is it used?

The MitraClip procedure is a catheter-based treatment designed to repair a leaking mitral valve. A tiny clip (MitraClip) is delivered via a thin tube (catheter) inserted through a small puncture in the groin. Using X-ray and echo guidance, the clip is positioned on the mitral valve and clamps the valve’s leaflets together, reducing the backflow of blood.

MitraClip is typically used for severe mitral regurgitation in patients who have symptoms and are at high risk for open-heart surgery. It offers an alternative to traditional surgery, aiming to relieve symptoms and improve valve function without needing a large chest incision. In fact, the U.S. FDA approved MitraClip in 2013 for patients who cannot safely undergo surgery, and newer versions continue to improve results.

Who is a candidate for MitraClip?

MitraClip is recommended for patients who meet the following conditions:

• Severe regurgitation with symptoms: Patients should have moderate-to-severe MR and noticeable symptoms like shortness of breath or fatigue despite optimal medical therapy.
• High surgical risk: Often elderly patients or those with other serious health issues (such as lung disease, kidney problems, or diabetes) who would face a high risk from open-heart surgery.
• Favorable anatomy: The heart’s structure and the mitral valve leaflets must allow clip placement. This is evaluated by detailed imaging (TEE, CT scan).
• No major contraindications: There should be no large clots in the heart, no active infection (endocarditis), and no other valve or coronary surgery needed at the same time. Also, the mitral valve should not be severely calcified or stenotic, and the patient must be able to take necessary blood thinners.

In summary, MitraClip is a valuable option for patients with advanced MR who have symptoms and who cannot undergo open surgery safely.

Procedure Steps (Briefly)

1. Preparation: The patient arrives on the day of the procedure. A nurse places an IV line and monitors vital signs. Mild sedation (or general anesthesia) is given so the patient is comfortable.
2. Accessing the Heart: A small incision is made in the groin to access a femoral vein. A catheter (a thin, flexible tube) is inserted and guided up to the heart using real-time X-ray and transesophageal echocardiography.
3. Positioning the Clip: Once the catheter reaches the left atrium (often after crossing the atrial septum), the doctor maneuvers the MitraClip device through the catheter to the mitral valve. The clip is opened and positioned so it grasps the valve’s leaflets. When released, the clip holds the leaflets together, reducing mitral regurgitation.
4. Checking Results: The medical team evaluates the valve function with ultrasound. If the leak is sufficiently reduced, the clip is deployed permanently. If not, a second clip may be placed to further reduce regurgitation.
5. Completion and Recovery: After the clip is secured, catheters are removed. The groin incision is closed with pressure or a closure device. The patient is transferred to a recovery area for monitoring. Most patients stay in the hospital 1–3 days for observation (typically 2–3 days on average). Before discharge, the patient receives instructions on wound care, medications (such as aspirin and a second antiplatelet), and activity restrictions.

Advantages Compared to Open-Heart Surgery

• Minimally invasive: MitraClip requires only a tiny puncture in the groin rather than opening the chest. This means less pain and a much shorter hospital stay.
• Faster recovery: Patients often go home within a few days and can resume normal activities in weeks, whereas open surgery typically needs longer healing.
• Effective symptom relief: By improving valve closure, most patients experience a prompt reduction in symptoms like shortness of breath and fatigue, leading to better daily function.
• Improved quality of life: Studies report that quality of life and exercise capacity improve significantly after MitraClip. Patients often return to activities they could not do before.
• Lower procedural risk: Without a sternotomy (breastbone opening), the risk of major complications (such as serious infection, bleeding, or lung issues) is generally lower than with conventional surgery. This makes MitraClip a safer choice for older or frailer patients.
• Option for inoperable patients: For patients who are not candidates for surgery due to age or comorbidities, MitraClip may be the only way to fix the valve, potentially improving survival and symptoms where medical therapy alone would be insufficient.

Expected Results

Most patients notice improvement quickly after MitraClip. Within days to weeks, symptoms like breathlessness and fatigue often diminish, allowing better tolerance of exercise and daily activities. Echocardiography after the procedure typically shows a substantial reduction in mitral regurgitation, which helps the heart pump more efficiently.

Clinical follow-up indicates that MitraClip significantly enhances long-term outcomes for suitable patients. Quality of life scores tend to rise markedly, and many patients experience fewer hospitalizations for heart failure in the months and years following the procedure.

In summary, MitraClip offers a safe and effective treatment for properly selected patients with severe mitral regurgitation. By avoiding open surgery, it provides a realistic pathway to symptom relief and improved heart function for those who otherwise could not be treated surgically.

A Message to Patients

If you experience symptoms such as shortness of breath or fatigue related to mitral valve regurgitation, modern treatments such as the MitraClip procedure may help improve valve function without the need for open-heart surgery.

This treatment can reduce symptoms, improve blood flow within the heart, and support a better quality of life.

A detailed evaluation by a cardiologist is important to determine whether this procedure is the most appropriate treatment option for each patient.